Welcome to our dedicated page for Xylem SEC filings (Ticker: XYL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Xylem Inc. (NYSE: XYL) is a Fortune 500 global water solutions company that reports its financial and operational information to the U.S. Securities and Exchange Commission. The XYL SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, along with AI-powered tools that help explain the content and context of each document.
Among the key filings for Xylem are its Form 10-K annual reports, which typically include a comprehensive discussion of the business, risk factors, and financial statements, and Form 10-Q quarterly reports, which update investors on revenue, margins, cash flows, and segment performance. For example, Xylem’s third-quarter 2025 results were furnished to the SEC via a Form 8-K that referenced its earnings press release and discussed revenue from products and services, adjusted earnings per share, and adjusted EBITDA margin.
The company also files Form 8-K current reports to announce material events such as quarterly results, portfolio transactions, and other significant developments. Recent 8-K filings have covered financial results for quarters ended June 30 and September 30, 2025, with exhibits that include the full text of related press releases.
On this page, users can review Xylem’s historical and ongoing SEC submissions, including annual and quarterly reports, current reports, and other required documents. Stock Titan’s AI-generated summaries highlight important sections, clarify technical language, and point out items that may be relevant to investors, such as segment commentary, outlook statements, and references to restructuring or portfolio optimization.
In addition, the filings page can surface insider transaction reports (Form 4) and proxy-related disclosures when available, helping users monitor equity awards, share ownership changes, and governance matters. Real-time updates from EDGAR combined with AI analysis make it easier to navigate Xylem’s filings and understand how the company communicates its financial condition, risks, and strategic priorities to regulators and the market.
Xylem Inc. reported that its Board of Directors approved a new share repurchase program. The company is authorized to buy back up to $1.5 billion of its common stock. The program has no expiration date, allows open market or other lawful purchases, and may be suspended at the company’s discretion. The authorization does not require Xylem to repurchase any specific amount of shares.
Xylem Inc. is a global water technology company with 2025 revenue of $9.0 billion and about 22,000 employees, designing equipment, digital solutions and services across the water cycle. Operations are organized into four segments: Water Infrastructure, Applied Water, Measurement and Control Solutions, and Water Solutions and Services.
The business is diversified geographically, with $5.2 billion of 2025 revenue from the United States and the rest from Western Europe, emerging markets and other regions. Backlog was $4.615 billion at December 31, 2025, with roughly 60% expected to convert to 2026 revenue.
Xylem emphasizes customer centricity, profitable growth, operational excellence, sustainability leadership and a high‑impact culture. The company has set 2025 and 2030 sustainability goals, updated science‑based emissions targets after the Evoqua acquisition, and is pursuing net zero greenhouse gas emissions across its value chain before 2050.
Xylem Inc. reported strong fourth-quarter and full-year 2025 results, highlighted by record annual revenue of $9.0 billion, up 6% on a reported basis and 5% organically. Full-year earnings per share were $3.92, with adjusted EPS of $5.08, up 19%.
Fourth-quarter revenue was $2.4 billion, up 6% reported and 4% organically, with orders of $2.4 billion, up 9% reported and 7% organically. Adjusted Q4 EPS was $1.42, up 20%, and adjusted EBITDA margin reached 23.2%, driven by productivity savings and pricing.
Net income attributable to Xylem for 2025 was $957 million, or $3.92 per diluted share, and operating income rose to $1.22 billion. Cash and cash equivalents increased to $1.48 billion, while long-term debt decreased to $1.41 billion. The Board declared a quarterly dividend of $0.43 per share, an 8% increase.
For 2026, Xylem forecasts revenue of $9.1–$9.2 billion, 2–4% organic growth, with adjusted EPS of $5.35–$5.60 and an adjusted EBITDA margin of 22.9–23.3%. The company also targets a free cash flow margin of 10.2–11%, reflecting expectations for continued profitable growth.
Xylem Inc. insider files Form 4 for tax-related share withholding
An executive officer of Xylem Inc. (EVP & President, WSS) reported a routine stock transaction involving company common stock on 01/02/2026. The filing shows that 457 shares of Xylem common stock were withheld at a price of $136.18 per share to cover taxes due when previously granted restricted stock units vested. After this tax withholding, the reporting person directly beneficially owns 72,545 shares of Xylem common stock, which includes additional shares from dividend reinvestment.
Xylem Inc. executive vice president and president of WSS, Rodney Aulick, reported a tax-related share withholding on 12/15/2025. A total of 1,840 shares of Xylem common stock were withheld at $138.25 per share to satisfy the tax liability triggered by the vesting of restricted stock units granted on December 9, 2022 under the Amended and Restated Evoqua Water Technologies Corp. 2017 Equity Incentive Plan, which were converted to Xylem restricted stock units in connection with the merger on May 24, 2023. After this transaction, Aulick directly beneficially owns 72,826 shares of Xylem common stock.
Xylem Inc. (XYL) director Victoria D. Harker reported an open‑market sale of 1,700 shares of common stock at a weighted average price of $148.14 on November 4, 2025. According to the Form 4, the shares were executed within a price range of $148.135 to $148.135.
Following the transaction, Harker beneficially owns 16,875 shares directly. The filing lists no derivative securities transactions.
Xylem (XYL) received a Form 144 notice indicating a planned sale of 1,700 common shares, with an aggregate market value of $251,829.50. The planned sale lists Morgan Stanley Smith Barney LLC as broker and targets the NYSE, with an approximate sale date of 11/04/2025.
The filing lists prior acquisitions via restricted stock vesting under a registered plan on 05/11/2015 (1,213 shares) and 05/10/2016 (487 shares). It also discloses a sale during the past three months: 1,800 shares for $258,541.74 on 08/04/2025 by Victoria Harker. Xylem had 243,469,063 shares outstanding as of the disclosure.
Xylem Inc. (XYL) reported an insider transaction by EVP, CPSO Claudia S. Toussaint. On 10/30/2025, a revocable trust for which she is trustee sold 10,421 shares of common stock at a weighted average price of $152.64, with executions ranging from $152.51 to $152.98. Following the sale, the filing shows 31,250 shares indirectly owned by the Claudia S. Toussaint Revocable Trust and 3,939 shares directly owned.
Form 144 filing: A stockholder filed notice to sell up to 10,421 shares of common stock, with an aggregate market value of $1,590,557.23. The planned sales may occur on the NYSE around 10/30/2025 through Morgan Stanley Smith Barney LLC Executive Financial Services.
The shares were acquired via restricted stock vesting under a registered plan on 02/21/2019 (1,401 shares), 02/27/2023 (3,792), 03/01/2023 (1,185), and 03/01/2024 (4,043), totaling 10,421 shares. Shares outstanding were 243,469,063; this is a baseline figure, not the amount being offered.
Xylem Inc. reported Q3 results with revenue of $2,268 million, up from $2,104 million a year ago. Net income was $226 million and diluted EPS was $0.93, compared with $0.89 last year. Gross profit rose to $883 million and operating income increased to $334 million. Interest expense declined to $6 million. The quarter included a $37 million loss on sale of businesses.
For the first nine months, revenue reached $6,638 million and operating cash flow was $698 million. Cash and cash equivalents stood at $1,191 million, and total assets were $17,295 million. The company closed acquisitions of EnviroMix for $106 million and Simply Clean for $7 million, and completed the Vacom Systems asset acquisition with total consideration of $42 million. It divested the Evoqua Magneto business for $61 million and recorded a $39 million loss tied to classifying the international metering business as held for sale. Q3 restructuring charges were $23 million, with $70 million year-to-date.